Fewer needles, same results: monthly anemia drug effective for kidney patients
NCT ID NCT07025460
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 29 times
Summary
This study tested whether a once-monthly injection of darbepoetin alfa can keep hemoglobin levels stable in people with advanced chronic kidney disease who are not on dialysis. 40 Korean adults completed the 12-week evaluation, and the monthly dosing was found to be as effective as the standard every-2-week schedule. The goal is to reduce injection burden and improve convenience for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institutional Review Board, Gangnam Severance Hospitial Yonsei University College of Medicine
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.